Reference number : 236-2018-2019-Q1-00130, amendment number : , agreement type : G, recipient legal name : Singaravelu, Ragunath, recipient country : CA, recipient province : ON, recipient city : Ottawa, recipient postal code : K1Y 4E9, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 123750.0, agreement start date : 2018-05-01, agreement end date : 2021-01-31, description english : CRISPR/Cas9 mediated screening to identify endogenous non-coding sensitizers to oncolytic virotherapy, description french : CRISPR/Cas9 mediated screening to identify endogenous non-coding sensitizers to oncolytic virotherapy, expected results english : nan, expected results french : nan, additional information english : nan, additional information french : nan, owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada